Identification and Target-Modification of SL-BBI: A Novel Bowman–Birk Type Trypsin Inhibitor from Sylvirana latouchii
Open Access
- 28 August 2020
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 10 (9) , 1254
Abstract
The peptides from the ranacyclin family share similar active disulphide loop with plant-derived Bowman–Birk type inhibitors, some of which have the dual activities of trypsin inhibition and antimicrobial. Herein, a novel Bowman–Birk type trypsin inhibitor of the ranacyclin family was identified from the skin secretion of broad-folded frog (Sylvirana latouchii) by molecular cloning method and named as SL-BBI. After chemical synthesis, it was proved to be a potent inhibitor of trypsin with a Ki value of 230.5 nM and showed weak antimicrobial activity against tested microorganisms. Modified analogue K-SL maintains the original inhibitory activity with a Ki value of 77.27 nM while enhancing the antimicrobial activity. After the substitution of active P1 site to phenylalanine and P2′ site to isoleucine, F-SL regenerated its inhibitory activity on chymotrypsin with a Ki value of 309.3 nM and exhibited antiproliferative effects on PC-3, MCF-7 and a series of non-small cell lung cancer cell lines without cell membrane damage. The affinity of F-SL for the β subunits in the yeast 20S proteasome showed by molecular docking simulations enriched the understanding of the possible action mode of Bowman–Birk type inhibitors. Further mechanistic studies have shown that F-SL can activate caspase 3/7 in H157 cells and induce apoptosis, which means it has the potential to become an anticancer agent.Keywords
This publication has 53 references indexed in Scilit:
- Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skinsAmino Acids, 2012
- Apoptosis and lysosome membrane permeabilization induction on breast cancer cells by an anticarcinogenic Bowman–Birk protease inhibitor from Vigna unguiculata seedsCancer Letters, 2010
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Pea (Pisum sativumL.) Protease Inhibitors from the Bowman−Birk Class Influence the Growth of Human Colorectal Adenocarcinoma HT29 Cellsin VitroJournal of Agricultural and Food Chemistry, 2005
- Peptide Tyrosine Arginine, a potent immunomodulatory peptide isolated and structurally characterized from the skin secretions of the dusky gopher frog, RanasevosaPeptides, 2005
- Bowman–Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1Carcinogenesis, 2005
- Ranacyclins, a New Family of Short Cyclic Antimicrobial Peptides: Biological Function, Mode of Action, and Parameters Involved in Target Specificity,,Biochemistry, 2003
- The role of the P2′ position of Bowman-Birk proteinase inhibitor in the inhibition of trypsinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1999
- Growth inhibition and cytotoxicity induced by Bowman‐Birk inhibitor concentrate in cisplatin‐resistant human ovarian cancer cellsNutrition and Cancer, 1998
- Effects of the bowman‐Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation andcis‐platinumNutrition and Cancer, 1996